HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold 2.0% of their position (20K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.67M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/11/2026ACC: 0001104659-26-082758
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-95.05K
Net shares
Net seller
$2.67M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
95.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
$133.63
Trade value
$2.67M
% of position
2.0%
7/8/2026
1.02M→995.99K
Common Stock
Direct
Shares
−75.05K
Price / share
—
Trade value
—
% of position
7.5%
7/10/2026
995.99K→920.94K
Total
Net shares
−95.05K
Net value
-$2.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | S · Sale | −20K | $133.63 | $2.67M | 2.0% | 1.02M | 995.99K |
| Common Stock Direct | 7/10/2026 | G · Gift | −75.05K | — | — | 7.5% | 995.99K | 920.94K |
| Total | −95.05K | -$2.67M | ||||||
Derivative Transactions0
No derivative transactions reported